Shefali Agarwal Epizyme, Inc. (EPZM) insider trading activity

Shefali Agarwal is of Epizyme, Inc.. Currently has a direct ownership of 0 shares of EPZM, which is worth approximately $0. The most recent transaction as insider was on Aug 12, 2022, when has been sold 286,539 shares (Common Stock, par value $0.0001) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

Shefali Agarwal Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 12 2022	SELL Sale (or disposition) back to the issuer	-	286,539 Reduced 100.0%	0 Common Stock, par valu...
Aug 09 2022	SELL Payment of exercise price or tax liability	$518,684 $1.39 p/Share	373,154 Reduced 56.65%	285,562 Common Stock, par valu...
Aug 09 2022	BUY Exercise of conversion of derivative security	$695,000 $1.39 p/Share	500,000 Added 43.15%	658,716 Common Stock, par valu...
Feb 28 2022	BUY Grant, award, or other acquisition	$2,960 $1.27 p/Share	2,331 Added 1.45%	158,716 Common Stock
Feb 07 2022	SELL Open market or private sale	$1,587 $1.5 p/Share	1,058 Reduced 0.67%	156,385 Common Stock, par valu...
Feb 02 2022	SELL Open market or private sale	$3,615 $1.37 p/Share	2,639 Reduced 1.65%	157,443 Common Stock, par valu...
Jan 26 2022	SELL Open market or private sale	$5,902 $2.02 p/Share	2,922 Reduced 1.79%	160,082 Common Stock, par valu...
Dec 06 2021	SELL Open market or private sale	$5,215 $2.93 p/Share	1,780 Reduced 1.08%	163,004 Common Stock, par valu...
Aug 16 2021	BUY Grant, award, or other acquisition	-	59,166 Added 26.57%	163,507 Common Stock, par valu...
Feb 04 2021	SELL Open market or private sale	$10,862 $11.21 p/Share	969 Reduced 0.92%	104,341 Common Stock, par valu...
Feb 01 2021	BUY Grant, award, or other acquisition	-	29,583 Added 21.93%	105,310 Common Stock
Jan 25 2021	SELL Open market or private sale	$32,770 $11.41 p/Share	2,872 Reduced 3.65%	75,727 Common Stock, par valu...
Dec 03 2020	SELL Open market or private sale	$34,148 $13.54 p/Share	2,522 Reduced 3.21%	76,089 Common Stock, par valu...

Also insider at

FATE

FATE THERAPEUTICS INC Healthcare

GRTS

Gritstone bio, Inc. Healthcare

Shefali Agarwal

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EPZM shares.

Notify only if

Value

Insider Trading

Get notified when an Epizyme, Inc. insider buys or sells EPZM shares.

Notify only if

Operation

Value

Type

News

Receive news related to Epizyme, Inc.

Track Activities on EPZM

Account